Clinical Trial Update: ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD [NA]

View source ↗

Summary

ALPHA LONG Study evaluates the BioMatrix AlphaTM Stent for coronary artery disease. The trial is active but not recruiting, with no results reported in this upd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BioMatrix AlphaTM Stent

Snippet

Sponsor: Biosensors Europe SA | Conditions: Coronary Artery Disease | NA | Status: ACTIVE_NOT_RECRUITING